TG Therapeutics | TGTX - Equity Capital And Reserves

Stock Price
33.56
Daily Change
-0.02 -0.06%
Monthly
16.21%
Yearly
-14.69%
Q2 Forecast
30.80

TG Therapeutics reported $648.02M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Amgen USD 8.66B 961M Dec/2025
Ardelyx USD 166.95M 12.67M Dec/2025
Arrowhead Research USD 568.42M 102.37M Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Curis USD 5.46M 19.45M Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
J&J USD 78.47B 0 Sep/2025
Karyopharm Therapeutics USD -292.93M 23.67M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Novavax USD -127.75M 28.92M Dec/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 648.02M 40.8M Dec/2025
Verastem USD 57.2M 72.72M Dec/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025